Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development

Selenium (Se)-containing molecules exert antioxidant properties and modulate targets associated with tumor growth, metastasis, angiogenesis, and drug resistance. Prevention clinical trials with low-dose supplementation of different types of Se molecules have yielded conflicting results. Utilizing se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakharia, Yousef, Bhattacharya, Arup, Rustum, Youcef M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828194/
https://www.ncbi.nlm.nih.gov/pubmed/29535842
http://dx.doi.org/10.18632/oncotarget.24297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828194/
https://www.ncbi.nlm.nih.gov/pubmed/29535842
http://dx.doi.org/10.18632/oncotarget.24297

Ejemplares similares